These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia. Mohammed IA, Streutker CJ, Riddell RH. Mod Pathol; 2002 Jun; 15(6):611-6. PubMed ID: 12065774 [Abstract] [Full Text] [Related]
5. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia? Türkmen IÇ, Başsüllü N, Uraz S, Yerdel MA, Memışoğlu R, Bülbül Doğusoy G. Turk Patoloji Derg; 2012 Jun; 28(3):251-8. PubMed ID: 23011828 [Abstract] [Full Text] [Related]
6. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53. Feith M, Stein HJ, Mueller J, Siewert JR. Dis Esophagus; 2004 Jun; 17(4):322-7. PubMed ID: 15569371 [Abstract] [Full Text] [Related]
11. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. DeMeester SR, Wickramasinghe KS, Lord RV, Friedman A, Balaji NS, Chandrasoma PT, Hagen JA, Peters JH, DeMeester TR. Am J Gastroenterol; 2002 Oct; 97(10):2514-23. PubMed ID: 12385432 [Abstract] [Full Text] [Related]
12. The usefulness of chromoendoscopy with methylene blue in Barrett's metaplasia and early esophageal carcinoma. Ormeci N, Savas B, Coban S, Palabiyikoğlu M, Ensari A, Kuzu I, Kursun N. Surg Endosc; 2008 Mar; 22(3):693-700. PubMed ID: 17704887 [Abstract] [Full Text] [Related]
16. Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux. Csendes A, Smok G, Burdiles P, Quesada F, Huertas C, Rojas J, Korn O. Dis Esophagus; 2000 Mar; 13(1):5-11. PubMed ID: 11005324 [Abstract] [Full Text] [Related]